Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes

Guillermo Garcia-Manero*, Elias Jabbour, Gautam Borthakur, Stefan Faderl, Zeev Estrov, Hui Yang, Sirisha Maddipoti, Lucy A. Godley, Nashat Gabrail, Jesus G. Berdeja, Ahmed Nadeem, Laurent Kassalow, Hagop Kantarjian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS